These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9462684)

  • 21. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines].
    Matsumoto Y; Takano H; Nagao S; Iglesias A; Fojo T
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2265-9. PubMed ID: 9422071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors.
    Oloumi A; MacPhail SH; Johnston PJ; Banáth JP; Olive PL
    Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental induction of apoptosis by a combination of etoposide and radiation treatment.
    Toda H; Hasegawa M; Hayakawa K; Kawashima M; Nakamura Y; Yamakawa M; Mitsuhashi N; Niibe H
    Anticancer Res; 2000; 20(1A):165-70. PubMed ID: 10769650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA topoisomerase II mutations and resistance to anti-tumor drugs.
    Vassetzky YS; Alghisi GC; Gasser SM
    Bioessays; 1995 Sep; 17(9):767-74. PubMed ID: 8763829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype.
    Matsumoto Y; Takano H; Fojo T
    Cancer Res; 1997 Nov; 57(22):5086-92. PubMed ID: 9371507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exposure to low concentrations of etoposide reduces the apoptotic capability of leukaemic cell lines.
    Liu WM; Oakley PR; Joel SP
    Leukemia; 2002 Sep; 16(9):1705-12. PubMed ID: 12200685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
    Richie JP
    J Urol; 2005 Sep; 174(3):931-2. PubMed ID: 16093994
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of drug sensitivity in yeast cells by the ATP-binding domain of human DNA topoisomerase IIalpha.
    Vilain N; Tsai-Pflugfelder M; Benoit A; Gasser SM; Leroy D
    Nucleic Acids Res; 2003 Oct; 31(19):5714-22. PubMed ID: 14500835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
    Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
    Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of etoposide to topoisomerase II in the absence of DNA: decreased affinity as a mechanism of drug resistance.
    Kingma PS; Burden DA; Osheroff N
    Biochemistry; 1999 Mar; 38(12):3457-61. PubMed ID: 10090731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
    Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
    Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell fusion studies to examine the mechanism for etoposide resistance in Chinese hamster V79 spheroids.
    Luo C; Johnston PJ; MacPhail SH; Banáth JP; Oloumi A; Olive PL
    Exp Cell Res; 1998 Sep; 243(2):282-9. PubMed ID: 9743588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of DNA-strand breaks in cells treated with F 11782, a catalytic inhibitor of topoisomerases I and II.
    Barret JM; Montaudon D; Etiévant C; Perrin D; Kruczynski A; Robert J; Hill BT
    Anticancer Res; 2000; 20(6B):4557-62. PubMed ID: 11205304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of resistance in a human cell line exposed to sequential topoisomerase poisoning.
    Saleem A; Ibrahim N; Patel M; Li XG; Gupta E; Mendoza J; Pantazis P; Rubin EH
    Cancer Res; 1997 Nov; 57(22):5100-6. PubMed ID: 9371509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity.
    Uesaka T; Shono T; Kuga D; Suzuki SO; Niiro H; Miyamoto K; Matsumoto K; Mizoguchi M; Ohta M; Iwaki T; Sasaki T
    J Neurooncol; 2007 Sep; 84(2):119-29. PubMed ID: 17361331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.
    Hu L; Li X; Liu Q; Xu J; Ge H; Wang Z; Wang H; Wang Z; Shi C; Xu X; Huang J; Lin Z; Pieper RO; Weng C
    Oncogene; 2017 Feb; 36(8):1145-1156. PubMed ID: 27593939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells.
    Engel R; Valkov NI; Gump JL; Hazlehurst L; Dalton WS; Sullivan DM
    Exp Cell Res; 2004 May; 295(2):421-31. PubMed ID: 15093741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide).
    Lönn U; Lönn S; Nylen U; Winblad G
    Cancer Res; 1989 Nov; 49(22):6202-7. PubMed ID: 2553248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.